ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,398Medicare Part D Prescriptions Filled, Including Refills

Rank: 95 out of 2604

$766K Total Retail Price of All Prescriptions

Rank: 52 out of 2604

599 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 6,424 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
OMEPRAZOLE 361 182 1 5
LEVOTHYROXINE SODIUM 361 248 1 4
SIMVASTATIN 324 261 3 2
HYDROCODONE-ACETAMINOPHEN 312 166 S3 4 1
LISINOPRIL 271 205 5 3
AMLODIPINE BESYLATE 231 200 6 6
GABAPENTIN 177 87 7 12
POTASSIUM CHLORIDE 174 123 8 16
METFORMIN HCL 168 120 9 7
TRAZODONE HCL 160 77 10 46
FUROSEMIDE 150 107 11 8
HYDROCHLOROTHIAZIDE 139 98 12 10
POLYETHYLENE GLYCOL 3350 137 28 13 42
TRAMADOL HCL 137 77 13 15
METOPROLOL TARTRATE 130 95 15 9
CYMBALTA 130 45 15 44
TAMSULOSIN HCL 114 53 17 30
NEXIUM 110 32 18 53
IBUPROFEN 110 48 18 32
NAMENDA 97 87 20 37
DONEPEZIL HCL 95 84 21 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 47 22 22
WARFARIN SODIUM 93 91 22 13
PAROXETINE HCL 91 37 24 62
CARVEDILOL 85 70 25 26
RISPERIDONE 84 0 26 65
LOSARTAN POTASSIUM 82 66 27 20
QUETIAPINE FUMARATE 78 41 28 66
CITALOPRAM HBR 78 41 28 18
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 49 28 91
SERTRALINE HCL 75 56 31 23
PREDNISONE 75 53 31 34
BUPROPION HCL SR 71 49 33 158
PROPRANOLOL HCL 70 17 34 154
FENTANYL 70 66 S2 34 48
FLUOXETINE HCL 70 42 34 49
LOVASTATIN 70 51 34 24
PRAVASTATIN SODIUM 68 53 38 14
RANITIDINE HCL 67 45 39 25
BUSPIRONE HCL 65 13 40 168
ABILIFY 64 0 41 130
SPIRONOLACTONE 63 39 42 78
MORPHINE SULFATE ER 63 28 S2 42 58
FENOFIBRATE 62 41 44 69
FLUTICASONE PROPIONATE 61 31 45 31
ZOLPIDEM TARTRATE 60 50 46 21
CLONIDINE HCL 60 43 46 56
BENAZEPRIL HCL 59 38 48 139
ATENOLOL 59 52 48 11
CYCLOBENZAPRINE HCL 59 32 R 48 43
ALENDRONATE SODIUM 54 28 51 29
DIVALPROEX SODIUM 54 20 51 81
ESCITALOPRAM OXALATE 53 20 53 73
SEROQUEL XR 53 0 53 236
ADVAIR DISKUS 52 22 55 41
OXYBUTYNIN CHLORIDE 51 25 56 92
ISOSORBIDE MONONITRATE ER 51 48 56 38
CRESTOR 50 24 58 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.